StockData
Sinovac Biotech Ltd logo

Sinovac Biotech Ltd (SVA) stock

SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 5, 2026Score 7/30
$6.47+0.00 (0.00%)

Close on Nov 17, 2026Market cap $464.94MP/E –Yield 850.08%

Sinovac Biotech market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Sinovac Biotech's market cap was $464.94M on Nov 11, 2026, against $464.94M a year earlier. Over the last 5 years it ranged from $464.06M to $642.44M, with a median of $464.94M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$464.94M0.0%
2025Dec 31, 2025$464.94M0.0%
2024Dec 31, 2024$464.94M+0.2%
2023Dec 29, 2023$464.06M0.0%
2022Dec 30, 2022$464.06M-27.8%
2021Dec 31, 2021$642.44M+0.4%
2020Dec 31, 2020$639.90M+39.0%
2019Dec 31, 2019$460.27M+15.8%
2018Dec 31, 2018$397.54M-11.5%
2017Dec 29, 2017$449.25M+33.8%
2016Dec 30, 2016$335.75M+5.2%
2015Dec 31, 2015$319.23M+9.8%
2014Dec 31, 2014$290.63M-13.8%
2013Dec 31, 2013$337.16M+96.0%
2012Dec 31, 2012$171.99M+44.0%
2011Dec 30, 2011$119.47M-38.5%
2010Dec 31, 2010$194.25M–

More Sinovac Biotech figures

See a number that looks wrong?